CORONAVIRUS SEMINAR SERIES
THE JOHN R. LAMONTAGNE LECTURE SERIES
2022 LaMontagne Lecture - March 22, 2022
The 2022 keynote speaker will be Jason McLellan, Ph.D., Welch Chair in Chemistry and Professor of Molecular Biosciences, The University of Texas at Austin. Dr. McLellan has worked to understand how viral protein structures operate. Viral protein structure and function are important for the development of vaccines and potential treatments for deadly viruses that have impacted the lives of billions of people. Dr. McLellan and his collaborators have engineered a key protein of coronaviruses for use in vaccines. His team has developed technology found in many leading vaccines against COVID-19 (Pfizer, Moderna, Johnson and Johnson, and Novavax). This discovery led to his selection as Texas Inventor of the Year by the State Bar of Texas’s Intellectual Property Section, which annually recognizes individuals and their inventions that have “significantly impacted the Texas economy.” McLellan and his colleagues also designed key proteins that form the basis of several vaccines. These vaccines are directed against coronaviruses as well as respiratory syncytial virus, a virus especially dangerous for young children and seniors. He is the winner of multiple scientific awards, and his research and expertise have been featured in multiple media outlets.
2021 LaMontagne Lecture - March 23, 2021
Our 2021 keynote speaker was Dr. Mary Estes, Distinguished Professor of Virology and Microbiology at Baylor College of Medicine in Houston, Texas. Her research group studies viruses that infect distinct types of cells (enterocytes, crypt cells, M cells) in the GI tract as probes to learn about the biology, host response and gene expression of these cells, using multidisciplinary approaches to probe the structure and molecular biology of GI viruses to understand the basic mechanisms that control virus replication, morphogenesis, virus-host interactions, and pathogenesis.
COVID-19 | LCID Researchers in the News
LCID at UT
Dr. Jaquelin Dudley, LCID Associate Director, was recently interviewed for an article in the Daily Beast on a potential nasal swab test that could be developed to determine if COVID patients will need to be hospitalized.
For more, go to t.co/VjoV9lLS58 t.co/jbxCGPQaB9
- Grace Kago, a grad student in LCID Director Dr. Shelley Payne's group, has worked to create a video in Gikuyu, which is spoken in Kenya. It provides basic information about the COVID pandemic and the virus. t.co/2wG25xYxxx
Center for Disease Control
#Flu can cause potentially serious complications in people with asthma, even if their condition is under control. There's still time to #FightFlu and reduce your flu risk. Get your flu shot today. t.co/YMdBRI6cW9 t.co/2xRwPw6ZSD
Join @ThePHF and CDC on Monday, Dec. 6, 2-3pm EST, for a webinar about communicating the importance of routine, #flu, and #COVID19 vaccinations this winter. Register today: t.co/rMtVdXJxCn. t.co/tKUnI4SKb9
World Health Organization
To get back on track, we need to ensure better & more equitable access to all health services – incl. #malaria prevention, diagnosis and treatment – by strengthening primary health care and stepping up both domestic & international investments t.co/M9sNo2Pn4u #EndMalaria t.co/Ja9W6nHYti
Sub-Saharan Africa continues to carry the heaviest #malaria burden, accounting for about 95% of all malaria cases and 96% of all deaths in 2020.
About 80% of deaths in the region are among children under 5 years of age t.co/M9sNo2Pn4u #EndMalaria t.co/OirJyNBDnN